ATXS icon

Astria Therapeutics
ATXS

Overview Fund Activity

105 hedge funds and large institutions have $310M invested in Astria Therapeutics in 2025 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 23 closing their positions.

Holders
105
Holders Change
-10
Holders Change %
-8.7%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
14
Increased
44
Reduced
30
Closed
23
Calls
$35K
Puts
–
Net Calls
+$35K
Net Calls Change
+$66K

Top Buyers

1
JPMorgan Chase & Co
1
JPMorgan Chase & Co
New York
$9.09M
2
Millennium Management
2
Millennium Management
New York
$15.9M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$4.09M
4
NCM
4
Nantahala Capital Management
Connecticut
$5.73M
5
VPC
5
Vestal Point Capital
New York
$24.2M

Top Sellers

1
RCM
1
RA Capital Management
Massachusetts
$0
2
UBS Group
2
UBS Group
Switzerland
$3.82M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$34.6M
4
ACM
4
ADAR1 Capital Management
Texas
$1.34M
5
RG
5
Redmile Group
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RTL
126
Red Tortoise LLC
Georgia
– – -298 Closed
AF
127
Allworth Financial
California
– – -277 Closed
S
128
SignatureFD
Georgia
– – -241 Closed
FFO
129
Fortitude Family Office
Arizona
– – -4 Closed
Group One Trading
130
Group One Trading
Illinois
– – – –
2 3 4 5
6